Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model

被引:30
作者
Bai, Yinlan [1 ]
Xue, Ying [1 ]
Gao, Hui [1 ]
Wang, Limei [1 ]
Ding, Tianbing [1 ]
Bai, Wentao [1 ]
Fan, Ailin [2 ]
Zhang, Hanfang [2 ]
An, Qunxing [3 ]
Xu, Zhikai [1 ]
机构
[1] Fourth Mil Med Univ, Dept Microbiol, Xian 710032, Shannxi Prov, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp, PLA, Dept Clin Lab, Xian 710033, Shannxi Prov, Peoples R China
[3] Fourth Mil Med Univ, Xijing Hosp, PLA, Dept Blood Transfus, Xian 710033, Shannxi Prov, Peoples R China
基金
中国国家自然科学基金;
关键词
Mycobacterium tuberculosis; ESAT-6; MPT64; expression; vaccine;
D O I
10.1016/j.pep.2007.11.016
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The completion of Mycobacterium tuberculosis genome sequence has opened a new way for the identification and characterization of bacterial antigens, such as ESAT-6, CFP10, MPT64, and Ag85 complex, which are helpful for tuberculosis control. In this work, genes of ESAT-6 and MPT64 were fused and expressed in Escherichia coli in form of inclusion bodies with a histidine tag. The expressed fusion protein was purified by nitrilotriacetic acid (Ni-NTA) affinity chromatography under denaturing conditions, and the yield was 18 mg/L of culture. In mice, the purified ESAT-6-MPT64 fusion protein elicited stronger humoral response, greater splenic lymphocyte stimulated index, and higher levels of IFN-gamma and IL-12 production than that of the single MPT64 inoculation group, and rendered modest protection on the experimental tuberculosis mouse models. In short, the ESAT-6-MPT64 fusion protein might be a potential candidate vaccine for tuberculosis. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:189 / 196
页数:8
相关论文
共 28 条
[2]   Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10 [J].
Arend, SM ;
Andersen, P ;
van Meijgaarden, KE ;
Skjot, RLV ;
Subronto, YW ;
van Dissel, JT ;
Ottenhoff, THM .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (05) :1850-1854
[3]  
BAI YL, 2003, J 4 MIL MED U, V24, P43
[4]   Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus calmette-gue'rin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis [J].
Bao, L ;
Chen, W ;
Zhang, HD ;
Wang, XY .
INFECTION AND IMMUNITY, 2003, 71 (04) :1656-1661
[5]   Has BCG attenuated to impotence? [J].
Behr, MA ;
Small, PM .
NATURE, 1997, 389 (6647) :133-134
[6]   Failure of the Mycobacterium bovis BCG vaccine:: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis [J].
Brandt, L ;
Cunha, JF ;
Olsen, AW ;
Chilima, B ;
Hirsch, P ;
Appelberg, R ;
Andersen, P .
INFECTION AND IMMUNITY, 2002, 70 (02) :672-678
[7]  
Brusasca PN, 2003, COMPARATIVE MED, V53, P165
[8]   Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence [J].
Cole, ST ;
Brosch, R ;
Parkhill, J ;
Garnier, T ;
Churcher, C ;
Harris, D ;
Gordon, SV ;
Eiglmeier, K ;
Gas, S ;
Barry, CE ;
Tekaia, F ;
Badcock, K ;
Basham, D ;
Brown, D ;
Chillingworth, T ;
Connor, R ;
Davies, R ;
Devlin, K ;
Feltwell, T ;
Gentles, S ;
Hamlin, N ;
Holroyd, S ;
Hornby, T ;
Jagels, K ;
Krogh, A ;
McLean, J ;
Moule, S ;
Murphy, L ;
Oliver, K ;
Osborne, J ;
Quail, MA ;
Rajandream, MA ;
Rogers, J ;
Rutter, S ;
Seeger, K ;
Skelton, J ;
Squares, R ;
Squares, S ;
Sulston, JE ;
Taylor, K ;
Whitehead, S ;
Barrell, BG .
NATURE, 1998, 393 (6685) :537-+
[9]   Cloning of a Mycobacterium tuberculosis gene encoding a purifed protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivity [J].
Coler, RN ;
Skeiky, YAW ;
Ovendale, PJ ;
Vedvick, TS ;
Gervassi, L ;
Guderian, J ;
Jen, S ;
Reed, SG ;
Campos-Neto, A .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (01) :224-233
[10]  
COLLINS DM, 1987, J GEN MICROBIOL, V133, P1431